Overexpression of DDX9 has been reported among many cancers, and elevated DDX9 may promote Wilms tumour metastasis, contribute to the progression of colorectal cancer through the activation of the NF-κB signalling pathway, and be related to the poor clinical outcome of lung cancer [12–14]. Here, DHX9 is linked to Wilms tumor.